Summary
The quality of life of a Hurler–Scheie patient who experienced improvement in several organ functions and regained mobility after 144 weeks of laronidase enzyme replacement therapy is described.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicating editor: Douglas Brooks
Electronic supplementary material
10545_2006_ESM_329.pdf
Impact of 144 weeks of laronidase therapy on body functions, endurance and general well-being in a Hurler–Scheie patient
Rights and permissions
About this article
Cite this article
Soutar, R.L., Mercer, J. & Wraith, J.E. Impact of 144 weeks of laronidase therapy on body functions, endurance and general well-being in a Hurler–Scheie patient. J Inherit Metab Dis 29, 590 (2006). https://doi.org/10.1007/s10545-006-0329-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-006-0329-5